Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkin Lymphoma, Follicular Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01329354
What this trial is testing

Rituximab and Autologous Effector Lymphocytes in Non-Hodgkin Follicular Lymphoma in Response to First Line Chemotherapy

Who this might be right for
Follicular LymphomaFollicular Non-Hodgkin´s LymphomaAutologous Effector Lymphocytes
Clinica Universidad de Navarra, Universidad de Navarra 38
Early research (Phase 1)Study completedNCT00849654
What this trial is testing

Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma

Who this might be right for
B-Cell LymphomaB-Cell Leukemia
Pharmacyclics LLC. 66
Early research (Phase 1)UnknownNCT05003141
What this trial is testing

PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies

Who this might be right for
Follicular LymphomaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaWaldenstrom Macroglobulinemia+5 more
Qilu Puget Sound Biotherapeutics (dba Sound Biologics) 110
Testing effectiveness (Phase 2)Ended earlyNCT00354822
What this trial is testing

Fludarabine,Cyclophosphamide and Rituximab Followed by Zevalin for Non-Follicular Indolent Lymphomas.

Who this might be right for
Lymphoma, Non-Hodgkin
A.O. Ospedale Papa Giovanni XXIII 25
Not applicableEnrolling By InvitationNCT07345377
What this trial is testing

Study on Treatment Mechanisms and Efficacy Prediction of Individualized Transcranial Magnetic Stimulation in Adults With Irritable Bowel Syndrome Using Multimodal MRI and High-Throughput Sequencing

Who this might be right for
Irritable Bowel Syndrome (IBS)PainDepressive Disorder, Major, Moderate
The Affiliated Hospital of Hangzhou Normal University 160
Testing effectiveness (Phase 2)Ended earlyNCT01159067
What this trial is testing

Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload

Who this might be right for
Iron OverloadAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+99 more
City of Hope Medical Center 1
Not applicableEnded earlyNCT00504205
What this trial is testing

MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Astex Pharmaceuticals, Inc. 30
Early research (Phase 1)Study completedNCT00315731
What this trial is testing

Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Follicular
GlaxoSmithKline 15
Very early researchStudy completedNCT01959477
What this trial is testing

Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+142 more
Case Comprehensive Cancer Center 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT05788081
What this trial is testing

Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.

Who this might be right for
Follicular Lymphoma Stage IIFollicular Lymphoma Stage IIIFollicular Lymphoma Stage IV
Olivia Newton-John Cancer Research Institute 40
Not applicableUnknownNCT04154228
What this trial is testing

Non-invasive Evaluation of Lymphoma Patients Based on Artificial Intelligence and PET/MRI

Who this might be right for
LymphomaNon Hodgkin LymphomaFollicular Lymphoma
Tel-Aviv Sourasky Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT00636792
What this trial is testing

A Phase II Study of VELCADE (Bortezomib) in Combination With Bendamustine and Rituximab in Subjects With Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Millennium Pharmaceuticals, Inc. 73
Testing effectiveness (Phase 2)UnknownNCT00041730
What this trial is testing

Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Favrille 90
Early research (Phase 1)Study completedNCT03440567
What this trial is testing

Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Mantle Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma+2 more
City of Hope Medical Center 16
Testing effectiveness (Phase 2)UnknownNCT00039156
What this trial is testing

BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Theradex
Not applicableLooking for participantsNCT06131801
What this trial is testing

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Who this might be right for
Hematologic MalignancyLeukemiaLymphoma+16 more
Children's Hospital Medical Center, Cincinnati 30
Large-scale testing (Phase 3)Looking for participantsNCT06522737
What this trial is testing

Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype

Who this might be right for
Lymphoma
SecuraBio 124
Early research (Phase 1)Ended earlyNCT00103272
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+32 more
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)UnknownNCT04707079
What this trial is testing

A Safety and Efficacy Study of Duvelisib in Relapsed/Refractory Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT00864227
What this trial is testing

Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)

Who this might be right for
Precursor B-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteBurkitt Lymphoma+3 more
Medical College of Wisconsin 54
Next Page